INSIDERFilingvia Quantisnow
BIO-key International Inc. logo

BIO-key International (BKYI) executive Depasquale bought 5,100 shares for $2,626 at an average $0.51

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Michael W Depasquale (executive at BIO-key International Inc., BKYI) reported that they bought 5,100 shares for $2,626 at an average $0.51 between Sep 12, 2023 and Sep 13, 2023. After these transactions the filing shows 121,827 shares held directly.

Reporting person
Depasquale Michael W
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Sep 12, 2023Open-market purchase (P)Common Stock1+100$0.51$51116,827 direct
Sep 13, 2023Open-market purchase (P)Common Stock1+5,000$0.52$2,575121,827 direct

Holdings before and after

  • Common Stock: 116,727 to 121,827 direct

Footnotes from the filing

  1. 1. Holdings do not include options to purchase 39,584 shares.

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Depasquale report in this BKYI Form 4?

Michael W Depasquale (executive at BIO-key International Inc., BKYI) reported that they bought 5,100 shares for $2,626 at an average $0.51 between Sep 12, 2023 and Sep 13, 2023. After these transactions the filing shows 121,827 shares held directly.

How many BKYI shares does Depasquale hold after this filing?

The filing shows 121,827 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for BKYI

Earlier insider filings at BKYI

Quantisnow market dataNASDAQ
BIO-key International Inc. logo
BKYI
BIO-key International Inc.
Market cap
30-day
Sector
Technology
Industry
Computer Software: Prepackaged Software
Get push alerts for BKYI

Follow BKYI and get a push notification the moment its next story breaks.

Full BKYI profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BKYI (BIO-key International Inc.) and more on Quantisnow.